Tranilast decreases OC formation induced by RANKL. by Tien Van Phan (583324)

High Levels of SOX5 Decrease Proliferative Capacity of Human B Cells, but Permit Plasmablast Differentiation by Mirzokhid Rakhmanov (580449)

Cortactin knockdown results in decreased FA turnover. by Alok Tomar (139282)

TIMP3 overexpression decreases tibial bone mechanical properties from macroscale to nanoscale mechanics. by Blandine Poulet (2939877)

“…<p>A, Von Kossa staining of tibia epiphysis and metaphysis of WT and TIMP3 Tg/Tg mice showed decreased trabecular bone in TIMP3 Tg/Tg mice (Magnification x2). …”

TMP decreased ROS generation in high glucose-treated endothelial cells. by Qiong Xu (204847)

Foskolin treatment to the fetal retina decreases corticogenesis. by Ciro Bonetti (147438)

“…(<b>b</b>) Quantification of cell cycle exit rate, (ratio between contra- and ipsi-lateral cortices), in E16.5 embryos upon administration of forskolin decreases corticogenesis rate (forskolin n = 5 DMSO n = 6 p = 0.00077, Student's t-test, two samples equal variants). …”

Adhesion strength is decreased in NEDD9−/− MEFs. by Jessie Zhong (171961)

Loss of either isoform of PLD decreases phagocytosis. by Wahida H. Ali (286470)

MES transiently decreases mitochondrial membrane potential. by Shingo Matsuyama (672132)

TMP decreased superoxide anions in high glucose-treated endothelial cells. by Qiong Xu (204847)

Comparison of glucose consumption and lactate production in culture medium of HL-1 cells exposed to LG, NG, HG and IHG between short- (12h) and long-time (72h) glucose treatment. by Patrick Mordel (17020879)

Decreased Th2 response in B7RP-1^+/− mice. by Bryan S. Clay (355764)

Ephrin-A2 and –A6 expression and EphA4 Tyr-602 phosphorylation decrease from nasal to temporal RGCs. by Ana Laura Ortalli (159899)

miR-100 decreases tumor size. by Bahauddeen M. Alrfaei (484859)

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Subjects:

Hsp90 depletion decreases stress resistance. by Michelle D. Leach (108675)